Endometriosis, polycystic ovary syndrome, and the thyroid: a review

IF 2.6 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Endocrine Connections Pub Date : 2023-12-01 DOI:10.1530/ec-23-0431
Signe Kirkegaard, Nanna Maria Uldall Torp, Stig Andersen, Stine Linding Andersen
{"title":"Endometriosis, polycystic ovary syndrome, and the thyroid: a review","authors":"Signe Kirkegaard, Nanna Maria Uldall Torp, Stig Andersen, Stine Linding Andersen","doi":"10.1530/ec-23-0431","DOIUrl":null,"url":null,"abstract":"<p>Endometriosis and polycystic ovary syndrome (PCOS) are common gynecological disorders that constitute a significant burden of disease in women of fertile age. The disorders share a link to female reproduction and infertility; however, divergent effects on menstrual cycle, related hormones, and body composition have been proposed. Disorders of the thyroid gland including abnormal thyroid dysfunction (hyperthyroidism or hypothyroidism) and/or markers of thyroid autoimmunity similarly show a female predominance and onset in younger age groups. We reviewed the literature on the association between endometriosis, polycystic ovary syndrome (PCOS), and thyroid disease up until July 1, 2023, and identified eight original studies on endometriosis and thyroid disease, and 30 original studies on PCOS and thyroid disease. The studies were observational and heterogenous regarding the design, sample size, and definitions of exposure and outcome; however, a tendency was seen towards an association between hyperthyroidism and endometriosis. Especially an association between endometriosis and slightly elevated levels of thyroid stimulating hormone receptor antibodies has been found and corroborated in studies from different populations. On the other hand, the literature review turned a focus towards an association between hypothyroidism and PCOS, however, with uncertainties as to whether the association is caused by hypothyroidism per se and/or the thyroid autoantibodies (thyroid peroxidase and thyroglobulin antibodies). More evidence is needed to substantiate an association between endometriosis, PCOS, and thyroid disease, and to differentiate between the role of thyroid function and thyroid autoimmunity. Furthermore, studies are warranted to extend knowledge on the different disease characteristics and underlying mechanisms.</p>","PeriodicalId":11634,"journal":{"name":"Endocrine Connections","volume":"235 1","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Connections","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/ec-23-0431","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Endometriosis and polycystic ovary syndrome (PCOS) are common gynecological disorders that constitute a significant burden of disease in women of fertile age. The disorders share a link to female reproduction and infertility; however, divergent effects on menstrual cycle, related hormones, and body composition have been proposed. Disorders of the thyroid gland including abnormal thyroid dysfunction (hyperthyroidism or hypothyroidism) and/or markers of thyroid autoimmunity similarly show a female predominance and onset in younger age groups. We reviewed the literature on the association between endometriosis, polycystic ovary syndrome (PCOS), and thyroid disease up until July 1, 2023, and identified eight original studies on endometriosis and thyroid disease, and 30 original studies on PCOS and thyroid disease. The studies were observational and heterogenous regarding the design, sample size, and definitions of exposure and outcome; however, a tendency was seen towards an association between hyperthyroidism and endometriosis. Especially an association between endometriosis and slightly elevated levels of thyroid stimulating hormone receptor antibodies has been found and corroborated in studies from different populations. On the other hand, the literature review turned a focus towards an association between hypothyroidism and PCOS, however, with uncertainties as to whether the association is caused by hypothyroidism per se and/or the thyroid autoantibodies (thyroid peroxidase and thyroglobulin antibodies). More evidence is needed to substantiate an association between endometriosis, PCOS, and thyroid disease, and to differentiate between the role of thyroid function and thyroid autoimmunity. Furthermore, studies are warranted to extend knowledge on the different disease characteristics and underlying mechanisms.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
子宫内膜异位症、多囊卵巢综合症与甲状腺:综述
子宫内膜异位症和多囊卵巢综合症(PCOS)是常见的妇科疾病,是育龄妇女的主要疾病负担。这两种疾病都与女性生殖和不孕有关,但对月经周期、相关激素和身体成分的影响却各不相同。甲状腺疾病包括甲状腺功能异常(甲状腺功能亢进或甲减)和/或甲状腺自身免疫标记物,这些疾病同样以女性为主,而且发病年龄较小。我们回顾了截至2023年7月1日有关子宫内膜异位症、多囊卵巢综合征(PCOS)和甲状腺疾病之间关系的文献,发现了8项有关子宫内膜异位症和甲状腺疾病的原创研究,以及30项有关多囊卵巢综合征和甲状腺疾病的原创研究。这些研究都是观察性的,在设计、样本大小、暴露和结果的定义方面存在差异;但是,研究发现甲状腺机能亢进与子宫内膜异位症之间存在关联。特别是子宫内膜异位症与促甲状腺激素受体抗体水平轻微升高之间存在关联,这一点已在不同人群的研究中得到证实。另一方面,文献综述将重点转向了甲状腺功能减退症与多囊卵巢综合症之间的关联,但对于这种关联是否是由甲状腺功能减退症本身和/或甲状腺自身抗体(甲状腺过氧化物酶和甲状腺球蛋白抗体)引起的,还存在不确定性。需要更多的证据来证实子宫内膜异位症、多囊卵巢综合症和甲状腺疾病之间的关联,并区分甲状腺功能和甲状腺自身免疫的作用。此外,还需要开展更多的研究,以扩展对不同疾病特征和潜在机制的认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Endocrine Connections
Endocrine Connections Medicine-Internal Medicine
CiteScore
5.00
自引率
3.40%
发文量
361
审稿时长
6 weeks
期刊介绍: Endocrine Connections publishes original quality research and reviews in all areas of endocrinology, including papers that deal with non-classical tissues as source or targets of hormones and endocrine papers that have relevance to endocrine-related and intersecting disciplines and the wider biomedical community.
期刊最新文献
Effectiveness of bariatric surgery on acquired hypothalamic obesity: a systematic review and meta-analysis. Association of incretin-based therapies with hepatobiliary disorders among patients with type 2 diabetes: a case series from the FDA adverse event reporting system. Pregnancy outcomes in type 2 versus type 1 diabetes: systematic review with meta-analyses. Gender-affirming hormone therapy: effects on cardiovascular risk and vascular function. STAT6 blockade ameliorates thyroid function in Graves' disease via downregulation of the sodium/iodide symporter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1